Verified factor-similar pair

SLYV vs XMVM

These two ETFs meet the same FF6 US comparison criteria: US-listed equity ETFs, the same USD model basis, at least one material non-market factor, and 100% overlap in statistically significant material factor exposure.

SMB HML RMW
Similarity score
88
Verified similar

The score combines exposure-level distance, factor-vector shape, market-beta closeness, and a small backtested relative-Sharpe term.

Quick Read

  • SLYV has the higher backtested relative Sharpe (1.104 vs 0.999).
  • SLYV has the lower published fee (0.15% vs 0.41%).
  • XMVM is cheaper on dividend valuation (98 vs 127, where 100 is each fund's historical median).
  • SLYV has the stronger regression fit (adjusted R-squared 0.957 vs 0.899).

These are screening signals, not a complete review of portfolio construction, turnover, taxes, or trading quality.

SLYV

State Street SPDR S&P 600 Small Cap Value ETF
SMB HML RMW
Adj. R2
0.957
Rel. Sharpe
1.104
Mkt beta
0.98
AUM
US$4.2B
MER
0.15%
Valuation
127

XMVM

Invesco S&P MidCap Value with Momentum ETF
SMB HML RMW
Adj. R2
0.899
Rel. Sharpe
0.999
Mkt beta
0.98
AUM
US$435M
MER
0.41%
Valuation
98

Factor Exposure Match

Blue bars compare raw factor beta magnitude. Green bars compare absolute t-stat strength. Dim bars indicate the t-stat is below 1.96.

SMB
SLYV
+0.80
|t|
+28.4
XMVM
+0.46
|t|
+9.4
diff +0.35
HML
SLYV
+0.39
|t|
+13.2
XMVM
+0.34
|t|
+7.0
diff +0.05
RMW
SLYV
+0.24
|t|
+7.3
XMVM
+0.25
|t|
+4.3
diff -0.02
CMA
SLYV
+0.09
|t|
+2.1
XMVM
+0.04
|t|
+0.6
diff +0.05
UMD
SLYV
-0.03
|t|
-1.9
XMVM
-0.06
|t|
-2.1
diff +0.03

Why This Pair Matches

Exposure level
85
Exposure shape
98
Mkt beta diff
0.00
Rel. Sharpe diff
0.106

This comparison focuses on measured factor exposure. It does not compare holdings methodology, turnover, tax handling, or issuer process. Backtested relative Sharpe is a secondary signal rather than a stand-alone forecast. See methodology.

SLYV fund page XMVM fund page US ETF Leaders US Universe
Important context

VerifiedBeta publishes educational ETF research, not personalized investment advice, portfolio management, or security recommendations. Funds that screen well here can still be unsuitable for your objectives, taxes, liquidity needs, or constraints. Review fund documents, methodology assumptions, and your own circumstances before acting. See the full disclaimer.